| 000 | 01623 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513114845.0 | ||
| 264 | 0 | _c19970424 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a1055-8330 | ||
| 024 | 7 |
_a10.1006/neur.1996.0048 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStrittmatter, M | |
| 245 | 0 | 0 |
_aSomatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations. _h[electronic resource] |
| 260 |
_bNeurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration _cDec 1996 |
||
| 300 |
_a359-66 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiogenic Monoamines _xcerebrospinal fluid |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDementia _xcerebrospinal fluid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHomovanillic Acid _xcerebrospinal fluid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Weight |
| 650 | 0 | 4 |
_aNeurotransmitter Agents _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aSomatostatin _xcerebrospinal fluid |
| 700 | 1 | _aGrauer, M T | |
| 700 | 1 | _aHamann, G F | |
| 700 | 1 | _aCramer, H | |
| 700 | 1 | _aSchimrigk, K | |
| 773 | 0 |
_tNeurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration _gvol. 5 _gno. 4 _gp. 359-66 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1006/neur.1996.0048 _zAvailable from publisher's website |
| 999 |
_c9099080 _d9099080 |
||